Nutrition Clinique et Metabolisme最新文献

{"title":"L’apport alimentaire en micronutriments dans le trouble du spectre de l’autisme chez des enfants de l’ouest Algérien","authors":"Nawel Amraoui ,&nbsp;Nouria Dennouni-Medjati ,&nbsp;Majda Dali-Sahi ,&nbsp;Yahia Harek ,&nbsp;Baya Guermouche ,&nbsp;Cherifa Benosman","doi":"10.1016/j.nupar.2023.09.005","DOIUrl":"10.1016/j.nupar.2023.09.005","url":null,"abstract":"<div><p>Autism Spectrum Disorders (ASD) can affect the nutritional status of children. This study aimed to assess the daily dietary intakes (DDI) of micronutrients, as well as the frequency of consumption (FC) of different food groups, in children with ASD and compare them to those with typical development (TD). It will also determine to what extent these intakes comply with the Recommanded Dietary Allowances (RDA). The study included 52 children, 26 with ASD and 26 with TD. DDI and FC were gathered using a 7-day food diary. Among the DDI of micronutrient, only Vit B12 showed a significant difference between cases and controls, but the DDI was higher than the recommendations in both groups studied. All the children of our study sample had DDI lower than the RDA, in iron, calcium, vitamins E and K1. However, the most notable discrepancy with the recommendations was observed in iron intake (6.95<!--> <!-->±<!--> <!-->2.87<!--> <!-->mg/d vs 7.04<!--> <!-->±<!--> <!-->2.98<!--> <!-->mg/d, p<!--> <!-->&gt;<!--> <!-->0.05; RDA equal to 10<!--> <!-->mg/d) primarily due to low consumption of meat products, and in calcium (406.96<!--> <!-->mg/d vs 399.46<!--> <!-->mg/d, p<!--> <!-->&gt;<!--> <!-->0.05; RDA of 1000<!--> <!-->mg/d). Most of the children in this study had a FC of dairy products below the recommended consumption frequency. This study highlights the importance of improving dietary guidance for both groups studied, with particular attention to children with ASD to avoid any complications of ASD.</p></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"38 1","pages":"Pages 16-21"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139395739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"L’éditorial de la présidente de la SFNCM","authors":"Francisca Joly","doi":"10.1016/j.nupar.2024.02.001","DOIUrl":"https://doi.org/10.1016/j.nupar.2024.02.001","url":null,"abstract":"","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"38 1","pages":"Page 1"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139992670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"High coffee consumption is not associated with less liver fibrosis in non-alcoholic steato-hepatitis: Results of the COCANASH study","authors":"Hugues Blondon ,&nbsp;Marc Delord ,&nbsp;Simona Cosconea ,&nbsp;Simona Tirziu ,&nbsp;Marie-Pierre Ripault ,&nbsp;Florent Ehrhard ,&nbsp;Matthieu Schnee ,&nbsp;Khaldoun Elriz ,&nbsp;Mathilde Fron ,&nbsp;Kamel Benghalia ,&nbsp;Margot Laly ,&nbsp;Sylvie Roussin-Bretagne ,&nbsp;Carelle Koudougou ,&nbsp;Gwenaelle Petit-Aubert ,&nbsp;Vincent Mace ,&nbsp;Michel Chochon ,&nbsp;Cécile Garceau ,&nbsp;Philippe Colardelle ,&nbsp;Ludovic Lagin ,&nbsp;Mélody Fort ,&nbsp;Cédric Villain","doi":"10.1016/j.nupar.2023.10.001","DOIUrl":"10.1016/j.nupar.2023.10.001","url":null,"abstract":"<div><h3>Background</h3><p>The beneficial effect of coffee consumption on the progression of liver fibrosis in NASH is controversial.</p></div><div><h3>Aims</h3><p>To compare coffee consumption in NASH patients with and without advanced fibrosis.</p></div><div><h3>Methods</h3><p>Cross-sectional observational study on 97 patients with NASH diagnosed by histology or the association of steatosis, metabolic syndrome, elastometry<!--> <!-->&gt;<!--> <!-->6<!--> <!-->kPa, and exclusion of other liver diseases. Usual coffee and caffeine intake were assessed using a standardized questionnaire. Liver fibrosis was evaluated by elastometry (advanced fibrosis if ≥<!--> <!-->10<!--> <!-->kPa).</p></div><div><h3>Results</h3><p>Among the 97 patients, 49 patients (51%) had non-advanced fibrosis (group 1) and 48 (49%) advanced fibrosis (group 2). The mean consumption of caffeine from coffee was 251<!--> <!-->mg<!--> <!-->±<!--> <!-->293 per day in group 1 and 257<!--> <!-->mg<!--> <!-->±<!--> <!-->286 per day in group 2 (<em>P</em> <!-->=<!--> <!-->0.92). In multivariable analysis, the odds ratio for the mean consumption of caffeine from coffee (100<!--> <!-->mg/d) between groups was 1.00 (1.00–1.00, <em>P</em> <!-->=<!--> <!-->0.92). There was no correlation between elastometry and the consumption of caffeine from coffee.</p></div><div><h3>Conclusion</h3><p>We found no relationship between caffeine or coffee consumption and the degree of liver fibrosis in NASH. Our result does not support a beneficial effect of coffee consumption on the progression of fibrosis in NASH.</p></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"38 1","pages":"Pages 22-26"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139195812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Human gut microbial ecology and association with postbiotics; prophylactic and diagnostic application","authors":"K. Hemamalini ,&nbsp;A.B. Chavhan ,&nbsp;B. Babitha ,&nbsp;J. Madhavi ,&nbsp;M.K. Verma","doi":"10.1016/j.nupar.2023.12.003","DOIUrl":"10.1016/j.nupar.2023.12.003","url":null,"abstract":"<div><p>The microbial ecology of the human gut is made up of many different species of beneficial microorganisms, mostly bacteria. The integrity of the gut and general health are crucially dependent on these beneficial bacterial species. A variety of microbial communities reside in the human gut in symbiotic interactions, the majority of which are advantageous. According to reports, aberrant bacterial species colonization causes gut dysbiosis and serves as a catalyst for a number of human diseases. Understanding the diverse microbial species that live in the human gut and how they are related to human health and a number of disorders has been the subject of extensive research. Less research has been done on the postbiotics, such as chemistry and biochemistry, and their connections to human health. Postbiotics are defined as non-viable microbial cells, metabolic metabolites, and their microbial by-products released after lysis. Understanding the postbiotic landscape is essential to determining its source and method of synthesis, whether natural or artificial. Therefore, it is crucial to profile the ecology of the gut's microbes as well as the habitat since these factors have an impact on the postbiotic metabolites that are created. In order to relate human health and disease based on postbiotic rather than microbial species, it will be more important to address specific metabolites. The present study stresses the importance of gut microbial ecology in human physiology and health. Postbiotics profiles may be helpful in gaining access to gut ecology, and these molecular markers may act as early diagnostic tools for a variety of disorders. The most recent studies show that postbiotics increase immunological function, allergic reactions, neurological diseases, acute and chronic diarrhoea, and immune function. In the future, effort can be made to develop a quantitative-effect relationship evaluation method that is more rational, scientific, and better to give stronger support for the healthy and long-term development of postbiotic preparations.</p></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"38 2","pages":"Pages 71-81"},"PeriodicalIF":0.6,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139820754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Board","authors":"","doi":"10.1016/S0985-0562(24)00002-5","DOIUrl":"10.1016/S0985-0562(24)00002-5","url":null,"abstract":"","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"37 2","pages":"Page ii"},"PeriodicalIF":0.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143274534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Actualités de la pharmacothérapie de l’obésité en 2023","authors":"Pierre Bel Lassen ,&nbsp;Judith Aron-Wisnewsky","doi":"10.1016/S0985-0562(24)00015-3","DOIUrl":"10.1016/S0985-0562(24)00015-3","url":null,"abstract":"<div><div>Significant progress have been made in the management of obesity thanks to the emergence of effective drug treatments, combined with dietary advice and regular physical activity. Unlike previous drugs tested, these new therapies allow for significant weight loss without serious side effects. They act primarily by increasing feelings of satiety and reducing food intake without frustration. GLP1 receptor agonists, such as liraglutide and semaglutide, are already recommended therapeutic options for the management of obesity in France. This review examines the mechanisms, efficacy, and side effects of the main drugs currently available on prescription.</div><div>© 2023 Société francophone nutrition clinique et métabolisme (SFNCM).</div><div>Published by Elsevier Masson SAS. All rights reserved.</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"37 2","pages":"Pages 2S70-2S73"},"PeriodicalIF":0.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143274552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Title Page","authors":"","doi":"10.1016/S0985-0562(24)00001-3","DOIUrl":"10.1016/S0985-0562(24)00001-3","url":null,"abstract":"","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"37 2","pages":"Page i"},"PeriodicalIF":0.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143274533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rôle de l’axe microbiote-intestin-cerveau dans la dérégulation du comportement alimentaire au cours de l’obésité et de l’hyperphagie boulimique : les mécanismes","authors":"Marie Galmiche ,&nbsp;Pierre Déchelotte","doi":"10.1016/S0985-0562(24)00007-4","DOIUrl":"10.1016/S0985-0562(24)00007-4","url":null,"abstract":"<div><div>Eating disorders (ED), particularly compulsive ED such as binge eating disorder (BED), play an important role in the pathophysiology of obesity. Recent data have highlighted the involvement of the microbiotagut-brain axis in the regulation of eating behavior; its deregulation could therefore contribute to the onset of obesity via the development or perpetuation of ED, in particular BED. This review highlights the various peripheral and central pathophysiological mechanisms linking intestinal dysbiosis and the disruption of eating behavior leading to obesity and BED. The main peripheral regulatory signals involved are peptides associated with food intake (ghrelin, GLP-1), short-chain fatty acids and bacterial components. The brain integration of peripheral and central signals modulating food intake, involving at homeostatic (arcuate nucleus of the hypothalamus) and hedonic (reward system) levels, will be described during BED and obesity. This better understanding of the role of the microbiota-gut-brain axis in the control of eating behavior in relation to the pathophysiology of obesity opens up prospects for innovative therapeutic strategies targeting gut microbiota reshaping.</div><div>© 2023 Société francophone nutrition clinique et métabolisme (SFNCM).</div><div>Published by Elsevier Masson SAS. All rights reserved.</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"37 2","pages":"Pages 2S16-2S25"},"PeriodicalIF":0.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143274539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Faire face à l’obésité : progrès dans la physiopathologie et la prise en charge médicale","authors":"Marie-Claude Brindisi ,&nbsp;Pierre Déchelotte","doi":"10.1016/S0985-0562(24)00004-9","DOIUrl":"10.1016/S0985-0562(24)00004-9","url":null,"abstract":"","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"37 2","pages":"Page 2S1"},"PeriodicalIF":0.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143274537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Surpoids et obésité de l’enfant et l’adolescent : quel parcours de soins en 2023 ?","authors":"Béatrice Dubern","doi":"10.1016/S0985-0562(24)00011-6","DOIUrl":"10.1016/S0985-0562(24)00011-6","url":null,"abstract":"<div><div>In link with the interministerial plan for obesity (2019-2022), the French National Authority for Health (HAS) has published in 2022 a guide to optimize the care pathway for overweight and obese children and adolescents to support healthcare professionals in its implementation. The guide particularly emphases on the importance of calculating Body Mass Index (BMI) throughout childhood, at every opportunity, to optimize screening for overweight and obesity. In case where excess weight has been established, it details the importance of multidisciplinary assessment of each situation, with considering several important aspects (socio-cultural, psycho-affective, etc.) and detailing the levers that professionals can use throughout this care pathway that must be coordinated and graduated on the long-term manner if it is to be effective.</div><div>© 2023 Société francophone nutrition clinique et métabolisme (SFNCM).</div><div>Published by Elsevier Masson SAS. All rights reserved.</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"37 2","pages":"Pages 2S46-2S51"},"PeriodicalIF":0.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143274555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}